companydata.dkcompanydata.dk

PHARMATEKET ApS: Financial statements 2021

CVR: 15183381

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

PHARMATEKET ApS (CVR 15183381) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -23,750 and a net result of DKK 224,787 compared with DKK 157,713 the year before. Equity in the 2021 report amounted to DKK 589,031. The solvency ratio was 66.9%.

Revenue
DKK 0
Gross Profit
DKK -23,750
Profit/Loss
DKK 224,787
Equity
DKK 589,031
Total Assets
DKK 879,849

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20210-24 t.225 t.589 t.-
20200-23 t.158 t.749 t.-
2019--23 t.379 t.5.6 mio.-
2018--31 t.409 t.5.2 mio.-
2017--31 t.388 t.4.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMATEKET ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Michael Maul Svarrer joins the board of PHARMATEKET ApSAug 9, 2021

As of August 9, 2021, Michael Maul Svarrer has joined the board of directors of PHARMATEKET ApS.

Sven Moesgaard leaves the board of PHARMATEKET ApSAug 9, 2021

As of August 9, 2021, Sven Moesgaard has left the board of directors of PHARMATEKET ApS.

PHARMATEKET ApS: The 2020 annual report is outJun 4, 2021

PHARMATEKET ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 157,713.

About PHARMATEKET ApS

PHARMATEKET ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1991. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Eli Wallin and Michael Maul Svarrer. The company is owned by PHARMA NORD EXPORT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,250 and a net result of DKK 197,932 compared with DKK 345,812 the year before. Equity in the 2025 report amounted to DKK 1,432,509.

Source: annual report 2025, Danish Business Authority